LGND logo Ligand Pharmaceuticals : LGND

LGND

Stock Data

$193.20

Change up

$0.23 (0.12%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and licensing a diverse portfolio of therapeutic products. It has a range of treatments for multiple myeloma, acute lymphoblastic leukemia, rare kidney diseases, osteoporosis, and pneumococcal diseases among others. Its products include Kyprolis, Evomela, Rylaze, and Veklury for COVID-19 treatment. The company collaborates with industry giants like Amgen, Merck, and Pfizer, providing innovative solutions such as Captisol technology for drug formulation. Founded in 1987, Ligand is headquartered in Jupiter, Florida, contributing to healthcare advancements globally.

All Ligand Pharmaceuticals Articles

19 Articles

1 2

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.